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The first systemic empirical analysis 
of AIDS leadership in 82 affected 
countries, conducted by a University 
of Cape Town (UCT) health economist, 
concludes that South Africa’s infamous 
but until-now anecdotal reputation for 
poor leadership is fully justified.
When it comes to the difference 
between actual and predicted HAART 
coverage, South Africa is more than 
twice below the quantum used as a 
scientific benchmark to label a country 
as performing ‘below expectations’. It is 
four or more times worse than Russia, 
Zambia and Zimbabwe and more than 
twice as bad as the Ukraine. Only Latvia 
is worse.
Published in the Journal of Public 
Health in September,1 the study’s 
primary controls were for levels 
of development (GDP per capita), 
external funding support, scale of the 
epidemic, other health-related demands 
and politico-institutional capacity 
(political stability, being an established 
democracy and percentage of births 
attended by skilled personnel).
Among countries that should have 
been able to achieve higher levels of 
both HAART and PMTCT coverage 
(given their individual contexts), South 
Africa languishes at the bottom of the 
table alongside Uruguay, Trinidad and 
Tobago. 
According to the study author, 
Professor Nicoli Nattrass, Director of 
UCT’s AIDS and Society Research Unit, 
these four countries have the resources 
and capacity to achieve ‘substantially 
higher’ levels of coverage. Once all 
other possible factors had been ruled 
out, the only conclusion left was that 
a lack of political will and leadership 
were to blame.
Ironically, her findings coincided 
with the two most influential South 
African AIDS leaders, Health Minister 
Manto Tshabalala-Msimang and 
President Thabo Mbeki, losing their jobs 
– for reasons totally unrelated to their 
controversial leadership in the local 
pandemic.
World’s longest ARV rollout a 
denialist ‘smokescreen’
The research should finally put to 
rest the repeated, beguiling selective 
and disingenuous official counter to 
international condemnation of the 
government’s erstwhile anti-AIDS 
ideology that South Africa has the 
world’s largest rollout of ART.
Nicoli introduces her study by 
saying that despite an unprecedented 
mobilisation of resources since 2003 
(Global Fund to Fight AIDS, TB 
and Malaria and the US President’s 
Emergency Plan for AIDS Relief 
(Pepfar)), the epidemic continues to 
outstrip attempts to rein it in. Last year 
2.1 million people died of AIDS and 
2.5 million became infected with HIV, 
bringing the global total of people living 
with HIV to 33.2 million.
‘Part of the problem is that as foreign 
assistance flows into AIDS-affected 
countries, inadequacies at the national 
level have become apparent, placing the 
spotlight on government leadership on 
AIDS.’
The author of one of the most 
comprehensive books yet on the ARV 
treatment ‘struggle’ in South Africa,2 
Nattrass wanted to probe whether 
reputations (good or bad) for AIDS 
leadership were deserved, or whether 
they simply reflected differential 
capacities and constraints. She began 
by framing the question of leadership 
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explicitly within the context of what 
was ‘possible and reasonable to expect’, 
choosing HAART, and to a lesser extent 
PMTCT rollout, as measures of policy. 
These had the most widely reported 
outcome variables available.
One of the multiple factors she 
used when considering country-
specific characteristics likely to impact 
on HAART coverage (beyond the 
immediate control of governments), was 
that Global Fund and Pepfar funds were 
distributed to a wide variety of NGOs 
and CBOs not necessarily in agreement 
with national policy on AIDS.
SA’s sorry tale of inefficiency
A memorable controversy in South 
Africa was when KwaZulu-Natal landed 
the first Global AIDS Fund millions 
while Pretoria missed the application 
deadline. Tshabalala-Msimang furiously 
insisted the funds be distributed 
nationally or ‘returned’ because KZN 
had failed to use her hastily assembled 
and then Global Fund-required ‘country 
co-ordinating committee’. The Global 
Fund has since stopped relying only 
on governments to distribute funds 
and turned to the corporate and NGO 
sectors for help.
The SA government faux pas had 
a disturbing sequel earlier this year 
when the health department failed 
to appoint a grant management team 
of six dedicated staff members by 
the required deadline of 16 March to 
qualify for an R80 million Global Fund 
instalment aimed at ‘behaviour change 
communication’. This put 13 of the 
country’s biggest HIV/AIDS charities 
at risk of running out of money and 
may force the retrenchment of up to 100 
vital HIV prevention campaign workers. 
Last year, Health Director-General, 
Thami Mseleku, failed to meet the 
tender contract renewal deadline for a 
major local AIDS prevention campaign, 
effectively putting it on ice for several 
months.
Other controls in Nattrass’ study 
included the total HIV-positive 
population, adult HIV prevalence rates 
and the number of disability-adjusted 
life years lost due to non-AIDS-related 
reasons, plus demographic factors. She 
used the percentage of births in the 
presence of a skilled health professional 
as an indicator of the reach of the health 
sector.
Using HAART coverage as the key 
indicator of commitment to combatting 
AIDS showed that Brazil, Cambodia, 
Mexico, Namibia, Thailand, Uganda 
and, to a lesser extent, Cuba and 
Rwanda, had performed ‘better than 
expected’, given their institutional 
characteristics, demographic challenges 
and levels of development. Nattrass 
concluded that these countries’ 
reputation as ‘poster children for good 
AIDS leadership was thus probably well 
deserved’.
Botswana, which has universal 
HAART coverage, was assessed 
to be performing ‘as expected’ 
but, ‘alarmingy’, performed below 
expectations when it came to PMTCT 
coverage, something that suggested 
urgent further research.
Nattrass cautioned that HAART 
coverage was ‘but one indicator’ of 
the wide range of policy responses 
necessary for combatting AIDS. ‘It tells 
us nothing about the characteristics of 
country-level programmes which may 
have relevance for clinical outcomes and 
the development of drug resistance,’ she 
added.
Chris Bateman
1.    Nattrass N. J Public Health 2008 (E-pub ahead of print).
2.    Nattrass N. Mortal Combat: AIDS Denialism and the Struggle 
for Antiretrovirals in South Africa. Cambridge: Cambridge 
University Press, 2007.
The research should finally 
put to rest the repeated, 
beguiling selective and 
disingenuous official 
counter to international 
condemnation of the 
government’s erstwhile 
anti-AIDS ideology that 
South Africa has the 
world’s largest rollout of 
ART.
November 2008, Vol. 98, No. 11  SAMJ
Izindaba November.indd   832 10/16/08   4:02:26 PM
